| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |
| A797918 | MACKLIN | 利鲁唑 | 10mM in DMSO | 96元/1ml; | 咨询 |
|
| A2423 | TCI | Riluzole | >98.0%(T)(HPLC) | 130元/5G; 630元/25G; | 咨询 |
基本信息 | 纯度/分析方法 | >98.0%(T)(HPLC) | | 分子式/分子量 | C8H5F3N2OS = 234.20 | | 外观与形状(20℃) | 固体 | | Reaxys-RN | 748759 | | PubChem物质ID | 253662378 | | Merck Index (14) | 8223 | | MDL编号 | MFCD00210213 |
技术规格 | Appearance | White to Light yellow powder to crystal | | Purity(HPLC) | min. 98.0 area% | | Purity(Nonaqueous Titration) | min. 98.0 % | | Melting point | 116.0 to 120.0 ℃ |
物性(参考值) | 熔点 | 118 ℃ | | 水溶性 | 不溶 | | 溶解性(可溶于) | 丙酮,二甲基甲酰胺,甲醇,乙醚 |
安全信息 | 图形或危害标志 |  | | 信号词 | 危险 | | 危险性说明 | H300 : 吞咽致命。
| | 防范说明 | P501 : 将内装物/容器送到批准的废物处理厂处理。 P270 : 使用本产品时不要进食、饮水或吸烟。 P264 : 作业后彻底清洗皮肤。 P301 + P310 + P330 : 如误吞咽:立即呼叫急救中心/医生。漱口。 P405 : 存放处须加锁。
|
相关法规 运输信息 | UN编号 | UN2811 | | 类别 | 6.1 | | 包装类别 | II | | 监管条件代码(*) | |
|
| 946916 | J&K | Riluzole | 98%, 一种谷氨酸盐拮抗剂 | 564元/5G; 2138元/25G; | 咨询 |
基本信息 | 分子式 | C8F3H5N2OS | | 分子量 | 234.20 | | 熔点 | 114-118 | | MDL编码 | MFCD00210213 | | 存储条件 | Freezer -20℃ | 产品描述 Riluzole是谷氨酸盐释放抑制剂,具有神经保护、抗癫痫、抗焦虑以及麻醉作用。 靶点(IC50 & Targe) NMDA receptor Sodium Channel 体外研究 Riluzole抑制谷氨基酸从培养的神经元和脑片释放。这些作用可能部分是由于谷氨酸能神经末梢电压依赖性钠离子通道的失活,以及G蛋白依赖性信号转导过程的激活。在非洲爪蟾卵母细胞中表达的离体兴奋性氨基酸受体的电生理学试验已经表明,Riluzole抑制N-甲基-D-天冬氨酸(NMDA) (IC50 = 18 μM)和红藻氨酸(IC50 = 167 μM)诱发的电流。Riluzole能够使蛙坐骨神经和大鼠小脑颗粒细胞中激活的钠离子通道以及在非洲爪蟾卵母细胞中表达的重组大鼠钠离子通道(Ki = 0.2 μM)稳定。Riluzole通过非竞争性NMDA受体阻断也会阻断一些谷氨酸的突触后作用。Tiluzole保护培养的神经元免受缺氧损伤,谷氨酸-酸摄取抑制剂的毒性作用,以及肌萎缩性侧索硬化患者CSF中毒性因子的损伤。[1] 体内研究 Riluzole能够轻易穿过血脑屏障。Riluzole在体内具有神经保护,抗痉挛,以及镇静作用。在短暂性脑缺血的啮齿动物模型中,能够观察到Riluzole治疗(8 毫克/千克 i.p.)完全抑制了局部缺血诱发的谷氨基酸大量释放。[1] 参考文献 [1] Doble A. Neurology, 1996, 47(6 Suppl 4), S233-241. [2] B. D. Kretschmer, et al. Naunyn-Schmiedeberg's Archives of P 安全信息 | 图形或危害标志 |  | | 提示语 | Danger | | 危险说明 | H301 | | 防范说明 | P301+P310 | | UN号码 | 2811 | | 危险分类 | 6.1 | | 包装等级 | III | | WGK | 3 | | RTECS | DL2830000 | | TSCA | 否 |
|
| H61328 | Alfa Aesar | 2-Amino-6-(trifluoromethoxy)benzothiazole | 98% | 2357元/5g; 5287元/25g; | 咨询 |
基本信息 MDL MFCD00210213 分子式 C8H5F3N2OS 分子量 234.20 熔点 114-118° 形态 Solid Beilstein 748759 GHS危害和防范说明 GHS符号
 Hazard Statements H300-H315-H319-H335 Fatal if swallowed.Causes skin irritation.Causes serious eye irritation.May cause respiratory irritation. Precautionary Statements P261-P280a-P301+P310a-P305+P351+P338-P405-P501a Avoid breathing dust/fume/gas/mist/vapours/spray.Wear protective gloves and eye/face protection.Wear protective gloves and eye/face protection.IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.Store locked up.Dispose of contents/container in accordance with local/regional/national/international regulations. 安全信息 危险等级 6.1 包装组 II 危险类别 25-36/37/38 Toxic if swallowed.Irritating to eyes, respiratory system and skin. 安全等级 20-26-36/37-45-60 When using do not eat or drink.In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.Wear suitable protective clothing and gloves.In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible).This material and its container must be disposed of as hazardous waste RTECS DL2830000 TSCA 否 |
| R116 | Sigma-Aldrich | Riluzole | solid | 1158.6元/25 MG; 6869.89元/250 MG; 11866.2元/500 MG; | 咨询 |
产品说明 包装 25 mg in poly bottle 250, 500 mg in glass bottle 生化/生理作用 谷氨酸释放抑制剂;抗惊厥 特点和优势 该化合物是由赛诺菲安万特开发的。想要浏览其他由制药公司开发的化合物以及已批准药物/候选药物清单, 请单击此处。 该化合物出现在受体分类和信号转导手册的钾离子通道页。欲浏览其他手册页,点击此处。 基本信息 | 经验(实验)分子式 | C8H5F3N2OS | | 分子量 | 234.20 | | MDL编号 | MFCD00210213 | | PubChem化学物质编号 | 24278006 | | NACRES | NA.77 |
产品性质 | 质量水平 | 100 | | 形式 | solid | | 创始人 | Sanofi Aventis | | SMILES string | Nc1nc2ccc(OC(F)(F)F)cc2s1 | | InChI | 1S/C8H5F3N2OS/c9-8(10,11)14-4-1-2-5-6(3-4)15-7(12)13-5/h1-3H,(H2,12,13) | | InChI key | FTALBRSUTCGOEG-UHFFFAOYSA-N | | Gene Information | human ... SCN10A(6336), SCN11A(11280), SCN1A(6323), SCN2A(6326), SCN3A(6328), SCN4A(6329), SCN5A(6331), SCN7A(6332), SCN8A(6334), SCN9A(6335) rat ... Scnn1g(24768) |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H300 | | 预防措施声明 | P301 + P310 + P330 | | 危险分类 | Acute Tox. 2 Oral | | 储存分类代码 | 6.1A - Combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials | | WGK | WGK 3 | | 个人防护装备 | Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges |
|
| PHR2499 | Supelco | Riluzole | Pharmaceutical Secondary Standard; Certified Reference Material | 2757.48元/300 MG; | 咨询 |
产品说明 一般描述 Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards 分析说明 These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. 其他说明 This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. 基本信息 | 经验(实验)分子式 | C8H5F3N2OS | | 分子量 | 234.20 | | MDL编号 | MFCD00210213 |
产品性质 | 等级 | certified reference material pharmaceutical secondary standard | | 形式 | solid | | CofA | current certificate can be downloaded | | 包装 | pkg of 300 mg | | 储存温度 | 2-8℃ | | SMILES string | Nc1nc2ccc(OC(F)(F)F)cc2s1 | | InChI | 1S/C8H5F3N2OS/c9-8(10,11)14-4-1-2-5-6(3-4)15-7(12)13-5/h1-3H,(H2,12,13) | | InChI key | FTALBRSUTCGOEG-UHFFFAOYSA-N |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H300 | | 预防措施声明 | P301 + P310 + P330 | | 危险分类 | Acute Tox. 2 Oral | | 储存分类代码 | 6.1B - Non-combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials | | WGK | WGK 3 |
|
| 1604337 | USP | Riluzole | United States Pharmacopeia (USP) Reference Standard | 3889.96元/200 MG; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C8H5F3N2OS | | 分子量 | 234.20 | | MDL编号 | MFCD00210213 | | PubChem化学物质编号 | 329751046 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | USP | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | Nc1nc2ccc(OC(F)(F)F)cc2s1 | | InChI | 1S/C8H5F3N2OS/c9-8(10,11)14-4-1-2-5-6(3-4)15-7(12)13-5/h1-3H,(H2,12,13) | | InChI key | FTALBRSUTCGOEG-UHFFFAOYSA-N | | Gene Information | human ... SCN10A(6336), SCN11A(11280), SCN1A(6323), SCN2A(6326), SCN3A(6328), SCN4A(6329), SCN5A(6331), SCN7A(6332), SCN8A(6334), SCN9A(6335) |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H300 | | 预防措施声明 | P301 + P310 + P330 | | 危险分类 | Acute Tox. 2 Oral | | 储存分类代码 | 6.1A - Combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials | | WGK | WGK 3 |
|
| 557324 | Sigma-Aldrich | Riluzole-CAS 1744-22-5-Calbiochem | A cell-permeable benzothiazole compound that potently inhibits glutamate release and blocks Na+ channels. | 1445.69元/50 MG; | 咨询 |
产品说明 一般描述 A cell-permeable benzothiazole compound that potently inhibits glutamate release and blocks Na+ channels. Reported to function as a polyglutamine aggregation inhibitor and stimulate the synthesis of nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and glial cell-derived neurotrophic factor (GDNF) in mouse astrocyte cultures. Offers neuroprotection, slows disease progression in amyotrophic lateral sclerosis (ALS) patients, and prolongs survival in animal models of Huntington′s disease (HD). A cell-permeable benzothiazole compound that potently inhibits glutamate release and blocks Na+ channels. Shown to function as a polyglutamine aggregation inhibitor and stimulates the synthesis of NGF, BDNF, and GDNF in mouse astrocyte cultures. Reported to offer neuroprotection, slow down disease progression in ALS (amyotrophic lateral sclerosis) patients, and prolong the lifespan of animal models of HD (Huntington’s disease). 包装 50 mg in Alu drum Packaged under inert gas 生化/生理作用 Cell permeable: yes Product does not compete with ATP. Reversible: no Primary Target Inhibits glutamate release and blocks Na+ channels 警告 Toxicity: Toxic (F) 重悬 Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C. 其他说明 Heiser, V., et al. 2002. Proc. Natl. Acad. Sci. USA99, 16400. Schiefer, J., et al. 2002. Mov. Disord.17, 748. Mizuta, I., et al. 2001. Neurosci. Lett.310, 117. Louvel, E., et al. 1997. Trends Pharmacol. Sci.18, 196. Mizoule, J., et al. 1985. Neuropharmacology24, 767. Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges. 法律信息 CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany 基本信息 | 经验(实验)分子式 | C8H5F3N2OS | | 分子量 | 234.20 | | MDL编号 | MFCD00210213 |
产品性质 | 质量水平 | 100 | | 测定 | ≥97% (HPLC) | | 形式 | solid | | manufacturer/tradename | Calbiochem® | | 储存条件 | OK to freeze protect from light | | 颜色 | white to off-white | | 溶解性 | HCl: 0.1 N DMSO: 40 mg/mL | | 痕量阳离子 | heavy metals: ≤20 ppm | | 运输 | ambient | | 储存温度 | 2-8℃ | | InChI | 1S/C8H5F3N2OS/c9-8(10,11)14-4-1-2-5-6(3-4)15-7(12)13-5/h1-3H,(H2,12,13) | | InChI key | FTALBRSUTCGOEG-UHFFFAOYSA-N |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H300 | | 预防措施声明 | P264 - P270 - P301 + P310 - P405 - P501 | | 危险分类 | Acute Tox. 2 Oral | | 储存分类代码 | 6.1A - Combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials | | WGK | WGK 3 |
|
| 004026 | Fluorochem | 2-Amino-6-(trifluoromethoxy)benzothiazole | 97% | 330元/1g; 594元/5g; 2156元/25g; | 咨询 |
基本信息 | CAS Number | 1744-22-5 | | MDL Number | MFCD00210213 |
安全信息 | 图形或危害标志 |  | | 危险性说明 | H315: Causes skin irritation. H319: Causes serious eye irritation. H335: May cause respiratory irritation.
| | 防范说明 | P233: Keep container tightly closed. P260: Do not breathe . P261: Avoid breathing . P264: Wash hands thoroughly after handling. P271: Use only outdoors or in a well-ventilated area. P280: Wear . P302 + P352: IF ON SKIN: Wash with plenty of soap and water. P304: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing.. P304 + P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P305 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P312: Call a POISON CENTER or doctor/physician if you feel unwell. P321: Specific treatment (see relevant procedures. on this label). P332 + P313: If skin irritation occurs: Get medical advice/ attention. P337 + P313: If eye irritation persists: Get medical advice/attention. P340: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P362: Take off contaminated clothing and wash before reuse. P403: Store in a well-ventilated place. P403 + P233: Store in a well-ventilated place. Keep container tightly closed. P405: Store locked up. P501: Dispose of contents/container to in accordance with local regulation .
|
|